- Home
- RDY vs CR Comparison
RDY vs CR Comparison
Compare RDY & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- CR
- Stock Information
- Founded
- RDY 1984
- CR 1855
- Country
- RDY India
- CR United States
- Employees
- RDY N/A
- CR N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- CR Metal Fabrications
- Sector
- RDY Health Care
- CR Industrials
- Exchange
- RDY Nasdaq
- CR Nasdaq
- Market Cap
- RDY 11.6B
- CR 10.9B
- IPO Year
- RDY N/A
- CR N/A
- Fundamental
- Price
- RDY $13.98
- CR $178.99
- Analyst Decision
- RDY Strong Buy
- CR Strong Buy
- Analyst Count
- RDY 1
- CR 5
- Target Price
- RDY $16.90
- CR $223.60
- AVG Volume (30 Days)
- RDY 1.1M
- CR 293.3K
- Earning Date
- RDY 10-24-2025
- CR 10-27-2025
- Dividend Yield
- RDY 0.51%
- CR 0.51%
- EPS Growth
- RDY 9.95
- CR 37.96
- EPS
- RDY 0.79
- CR 6.25
- Revenue
- RDY $3,851,623,984.00
- CR $2,268,100,000.00
- Revenue This Year
- RDY $6.29
- CR $10.97
- Revenue Next Year
- RDY $2.61
- CR $12.81
- P/E Ratio
- RDY $17.72
- CR $28.60
- Revenue Growth
- RDY 14.10
- CR 19.64
- 52 Week Low
- RDY $12.26
- CR $127.04
- 52 Week High
- RDY $16.17
- CR $203.89
- Technical
- Relative Strength Index (RSI)
- RDY 51.87
- CR 37.40
- Support Level
- RDY $13.79
- CR $175.63
- Resistance Level
- RDY $14.02
- CR $191.85
- Average True Range (ATR)
- RDY 0.23
- CR 5.48
- MACD
- RDY 0.05
- CR -1.27
- Stochastic Oscillator
- RDY 93.92
- CR 15.31
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.